心脏结节病的心脏正电子发射断层成像风险分层:系统评价与荟萃分析
该系统评价与荟萃分析纳入55项研究共5250例心脏结节病患者,评估PET影像参数的预后价值。结果显示氟脱氧葡萄糖异常摄取合并灌注缺损(OR 2.86)、异常灌注或FDG摄取(OR 2.69)、异常FDG摄取(OR 2.61)、右心室局灶性异常摄取(OR 6.27)及系列PET对免疫抑制治疗无反应(OR 8.43)均与主要不良心脏事件相关。
要点
- 右心室局灶性异常FDG摄取与MACE的OR为6.27(95%CI 3.19-12.32),预测价值较强。
- 系列PET显示对免疫抑制治疗无反应者,MACE风险OR为8.43(95%CI 3.25-21.85)。
- FDG异常摄取合并灌注缺损的OR为2.86(95%CI 1.74-4.71),异常FDG摄取OR为2.61(95%CI 1.51-4.50)。
核心结论
- 多种心脏PET参数在心脏结节病中具有风险分层价值,右心室局灶性摄取和系列PET对免疫抑制治疗无反应尤其预测MACE。
研究设计与样本
- 系统评价与荟萃分析,检索EMBASE、MEDLINE、PubMed、Cochrane Central Register of Controlled Trials、Cochrane Database of Systematic Reviews、CINAHL、ClinicalTrials.gov及欧盟临床试验注册库,纳入55项研究共5250例患者。
诊断标准与关键数值
- 异常FDG摄取合并灌注缺损与MACE相关,OR 2.86(95%CI 1.74-4.71;P<0.0001)。
- 异常灌注或FDG摄取与MACE相关,OR 2.69(95%CI 1.67-4.33)。
- 异常FDG摄取与MACE相关,OR 2.61(95%CI 1.51-4.50)。
- 右心室局灶性异常摄取与MACE相关,OR 6.27(95%CI 3.19-12.32;P<0.00001)。
- 系列PET对免疫抑制治疗无反应与MACE相关,OR 8.43(95%CI 3.25-21.85;P<0.0001)。
局限性
- QUIPS工具分析显示偏倚风险为低至中等,部分原因是各单项研究样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Although positron emission tomography (PET) imaging is well established for its diagnostic role in cardiac sarcoidosis, less is known about the prognostic value of PET and its use in risk stratification for major adverse cardiac events (MACE).
OBJECTIVES: The goal of this study was to perform a systematic review and meta-analysis looking at the prognostic value of PET imaging in patients with cardiac sarcoidosis.
METHODS: Study investigators systematically searched EMBASE (Excerpta Medica dataBASE), MEDLINE, PubMed, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, CINAHL (Cumulative Index to Nursing and Allied Health Literature), ClinicalTrials.gov, and the European Union Clinical Trial Registry for cardiac sarcoidosis and PET imaging. The primary outcome of interest was MACE.
RESULTS: The search revealed 3,010 records, of which 55 studies were included. This represented 5,250 patients. Factors associated with MACE included the following: the combination of abnormal fluorodeoxyglucose (FDG) uptake and perfusion defect, which had an OR of 2.86 (95% CI: 1.74-4.71; P < 0.0001); abnormal perfusion or FDG uptake, which had an OR of 2.69 (95% CI: 1.67-4.33); abnormal FDG uptake, which had an OR of 2.61 (95% CI: 1.51-4.50); focal abnormal right ventricular uptake, which had an OR of 6.27 (95% CI: 3.19-12.32; P < 0.00001); and a lack of response to immunosuppression on serial PET, which had an OR of 8.43 (95% CI: 3.25-21.85; P < 0.0001). A QUIPS (Quality in Prognostic Studies) tool analysis found a low to moderate risk of bias, particularly given the small sample sizes in the individual studies.
CONCLUSIONS: Multiple cardiac PET parameters provide risk stratification value in cardiac sarcoidosis. Focal right ventricular uptake and a lack of response to immunosuppressive therapy on serial PET imaging were particularly predictive of MACE.
引用
- Kafil TS, Shaikh OM, Fanous Y, et al. Risk Stratification in Cardiac Sarcoidosis With Cardiac Positron Emission Tomography: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2024. PMID: 39115497. doi:10.1016/j.jcmg.2024.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。